2026: Big Pharma is hitting the 'Patent Cliff,' with 70B in revenue at risk as blockbusters like Ozempic face expiration. But the industry is already using AI to snap up late-stage assets and find new ways to extend their monopolies. Health is a biological common, not a rent-seeking asset. We need to enforce generic accessibility and dismantle the automated extensions of medical scarcity. #BigPharma #HealthJustice #PatentCliff2026 #MedicalCommons #ActiveReclamation #ReVolt